WONDER-02: plastic stent vs. lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic pseudocysts-a multicentre randomised non-inferiority trial
Not Applicable
- Conditions
- Pancreatic Pseudocyst
- Registration Number
- JPRN-UMIN000052647
- Lead Sponsor
- The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
-A pseudocyst that is inaccessible via the EUS-guided approach -A plastic or lumen-apposing metal stent in situ -Coagulopathy (e.g., platelet count < 50,000/mm3 or prothrombin time international normalised ratio [PT-INR] >1.5) -Users of antithrombotic agents that cannot be discontinued according to the Japan Gastroenterological Endoscopy Society [JGES] guidelines -Patients who do not tolerate endoscopic procedures -Pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pancreatic pseudocyst resolution with lumen-apposing metal stents versus plastic stents in endoscopic ultrasound-guided drainage?
How does the efficacy of lumen-apposing metal stents compare to standard plastic stents for pancreatic pseudocyst drainage in the WONDER-02 trial?
What biomarkers are associated with successful endoscopic ultrasound-guided drainage outcomes in pancreatic pseudocyst patients using different stent types?
What are the potential adverse events and management strategies for endoscopic ultrasound-guided drainage using lumen-apposing metal stents versus plastic stents in pancreatic pseudocysts?
Are there any combination therapies or alternative interventions being explored alongside stent placement for pancreatic pseudocyst drainage in clinical trials?